IMMU-30. NOVEL HYPOMETHYLATING AGENT GSK-3484862 SENSITIZES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC IMMUNOTHERAPY

Authors: Kevin Li, Thomas Lai, Robert Prins, Richard Everson

Published: 2023-11-11

DOI: 10.1093/neuonc/noad179.0562

Source: Full article


Abstract

Abstract